What is it about?
Exhaled Nitric Oxide measurement (FeNO) is a simple test that has been used for many years in asthma management. It´s not clear yet if FeNO could be of value in COPD. This study is aimed to evaluate if FeNO could detect COPD patients at a higher risk of exacerbations
Featured Image
Why is it important?
For the first time, we demonstrate that COPD patients with persistent high FeNO levels are at a higher risk of moderate and severe COPD exacerbations.
Perspectives
FeNO could be used to target therapy (ICS) in COPD patients when aiming to prevent exacerbations
Bernardino Alcazar Navarrete
Read the Original
This page is a summary of: Longitudinal measurement of airway inflammation relates to a higher risk of exacerbation in COPD, September 2017, European Respiratory Society (ERS),
DOI: 10.1183/1393003.congress-2017.pa399.
You can read the full text:
Contributors
The following have contributed to this page
